GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » EV-to-EBITDA

ADGM (Adagio Medical Holdings) EV-to-EBITDA : -3.44 (As of May. 23, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adagio Medical Holdings's enterprise value is $23.31 Mil. Adagio Medical Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-6.78 Mil. Therefore, Adagio Medical Holdings's EV-to-EBITDA for today is -3.44.

The historical rank and industry rank for Adagio Medical Holdings's EV-to-EBITDA or its related term are showing as below:

ADGM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3.44   Med: -0.82   Max: -0.04
Current: -3.44

During the past 4 years, the highest EV-to-EBITDA of Adagio Medical Holdings was -0.04. The lowest was -3.44. And the median was -0.82.

ADGM's EV-to-EBITDA is ranked worse than
100% of 494 companies
in the Medical Devices & Instruments industry
Industry Median: 15.425 vs ADGM: -3.44

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-23), Adagio Medical Holdings's stock price is $1.15. Adagio Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.510. Therefore, Adagio Medical Holdings's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Adagio Medical Holdings EV-to-EBITDA Historical Data

The historical data trend for Adagio Medical Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings EV-to-EBITDA Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
- - - -

Adagio Medical Holdings Quarterly Data
Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only - - -1.42 - -2.66

Competitive Comparison of Adagio Medical Holdings's EV-to-EBITDA

For the Medical Devices subindustry, Adagio Medical Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adagio Medical Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's EV-to-EBITDA falls into.


;
;

Adagio Medical Holdings EV-to-EBITDA Calculation

Adagio Medical Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=23.309/-6.78
=-3.44

Adagio Medical Holdings's current Enterprise Value is $23.31 Mil.
Adagio Medical Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adagio Medical Holdings  (NAS:ADGM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Adagio Medical Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.15/-0.510
=At Loss

Adagio Medical Holdings's share price for today is $1.15.
Adagio Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.510.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Adagio Medical Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Adagio Medical Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Adagio Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.